Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (111-120 of 241) with videos related to

Pageof 25
Sort By:
Annals of the New York Academy of Sciences|June 18, 1999
Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipientsT A Bock, B L Ziegler, H J Bühring, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastomaB Meister, F Grünebach, F Bautz, et al.
Annals of the New York Academy of Sciences|July 19, 2001
The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cellsC Giesert, G Almeida-Porada, A Scheffold, et al.
Experimental Hematology|May 26, 1999
How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulationS Scheding, H Franke, V Diehl, et al.
Medical Microbiology and Immunology|December 24, 1997
Interstrain variation of immediate early DNA sequences and glycoprotein B genotypes in cytomegalovirus clinical isolatesH Hebart, M Greif, H Krause, et al.
Blood|May 9, 2001
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3H J Bühring, M Seiffert, C Giesert, et al.
Oncology|July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II studyJ T Hartmann, C H Köhne, H J Schmoll, et al.
Oncology Reports|May 19, 2011
The influence of gemcitabine on the CD4/CD8 ratio in patients with solid tumoursT Daikeler, K Maas, B Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Pageof 25

Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
Annals of the New York Academy of Sciences|June 18, 1999
Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipientsT A Bock, B L Ziegler, H J Bühring, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastomaB Meister, F Grünebach, F Bautz, et al.
Annals of the New York Academy of Sciences|July 19, 2001
The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cellsC Giesert, G Almeida-Porada, A Scheffold, et al.
Experimental Hematology|May 26, 1999
How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulationS Scheding, H Franke, V Diehl, et al.
Medical Microbiology and Immunology|December 24, 1997
Interstrain variation of immediate early DNA sequences and glycoprotein B genotypes in cytomegalovirus clinical isolatesH Hebart, M Greif, H Krause, et al.
Blood|May 9, 2001
The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3H J Bühring, M Seiffert, C Giesert, et al.
Oncology|July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II studyJ T Hartmann, C H Köhne, H J Schmoll, et al.
Oncology Reports|May 19, 2011
The influence of gemcitabine on the CD4/CD8 ratio in patients with solid tumoursT Daikeler, K Maas, B Weiss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 107 patients with non-small-cell lung cancer: a mature follow-up reportS Fetscher, W Brugger, R Engelhardt, et al.
Pageof 25